New-onset heart failure in the STOP-HF programme. Natriuretic peptide defines and tracks risk and enables earlier diagnosis of heart failure

Eur J Heart Fail. 2020 Feb;22(2):378-380. doi: 10.1002/ejhf.1661. Epub 2020 Jan 7.

Authors

Sarah McClelland^{1

2}, Shuaiwei Zhou¹, Eoin O'Connell¹, Joseph Gallagher^{1

2}, Fiona Ryan¹, Chris J Watson³, Mark Ledwidge^{1

2}, Kenneth McDonald^{1

2}

Affiliations

¹ STOP-HF Unit, St. Vincent's University Healthcare Group, Dublin 4, Ireland.
² School of Medicine, University College Dublin, Dublin, Ireland.
³ Centre for Experimental Medicine, Queen's University Belfast, Belfast, UK.

PMID: 31908097
DOI: 10.1002/ejhf.1661

No abstract available

Publication types

Letter

MeSH terms

Biomarkers / analysis
Heart Failure* / diagnosis
Heart Failure* / epidemiology
Humans
Natriuretic Peptide, Brain / analysis*

Substances

Biomarkers
Natriuretic Peptide, Brain